https://www.gosh.nhs.uk/news/gosh-x-raspberry-pi-can-you-hack-it/
Can You Hack It? | Join our Raspberry Pi Workshop
12 Aug 2022, 3 p.m.
Updated: 15 September 2022
Unfortunately, due to recent events we have been unable to fill this event and have had to cancel. We are planning to hold a similar event in the future.
Calling all GOSH outpatients! Join our digital making event on Saturday 17 September 2 - 3:30pm.
Together with the Raspberry Pi foundation, we'll explore physical computer building and programming. It'll be fun and interactive and introduce you to some basic coding concepts.
Email play.services@gosh.nhs.uk to register your interest.
Digital making workshop for outpatients and siblings
We'll be joined by the Raspberry Pi Foundation to deliver an in person workshop for Great Ormond Street Hospital (GOSH) outpatients and siblings. No previous coding knowledge needed! It's a taster session for all abilities and a mix of ages.
This hour and a half event is part of our Play Team's Activity Programme, supported by Morgan Stanley.
Email play.services@gosh.nhs.uk to register your interest.
Where?
GOSH DRIVE
First Floor
40 Bernard Street
Saturday 17 September 2 - 3:30pm
What workshops should we hold next?
We'd love to have your feedback – what type of technology-related activities could we put on in the future?
Email play.services@gosh.nhs.uk with your ideas.
Our new strategy has launched: Together We Power Care
We’re proud to share our new Trust Strategy for Great Ormond Street Hospital for Children, TOGETHER WE POWER CARE. This is our vision for the future, and the steps we’ll take to achieve our ambitions of delivering life-changing care for our children.
GOSH contributes to landmark UAE-UK paper on AI in healthcare
We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.
Landmark gene therapy study shows safety for children
Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.